Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia

Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia

Most children with non-classic congenital adrenal hyperplasia (NC-CAH) due to 21-hydroxylase deficiency are asymptomatic and do not require cortisol replacement therapy unless they develop symptoms of hyperandrogenemia. The current practice is to treat symptomatic children with hydrocortisone aimed...

Full description

Bibliographic Details
Main Authors: Sandy C. Liu, Malavika Suresh, Mutaz Jaber, Yesica Mercado Munoz, Kyriakie Sarafoglou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Endocrinology
Subjects:
congenital adrenal hyperplasia
anastrozole
aromatase inhibitor
hydrocortisone
bone maturation
growth
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1101843/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1101843/full

Similar Items